SE8804607L - Vattenformuleringar innehaallande ett piperidinylcyklopentylheptenonsyraderivat - Google Patents

Vattenformuleringar innehaallande ett piperidinylcyklopentylheptenonsyraderivat

Info

Publication number: SE8804607L
Authority: SE; Sweden
Prior art keywords: acid derivative; formulations containing; beta; alpha; piperidinylycylopentylphenonic
Prior art date: 1987-12-22

Application number

SE8804607A

Other languages

English (en)

Other versions

SE502288C2 (sv

SE8804607D0 (sv

Inventor

H Finch

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-12-22

Filing date

1988-12-21

Publication date

1989-06-23

1987-12-22 Priority claimed from GB878729823A external-priority patent/GB8729823D0/en

1988-02-25 Priority claimed from GB888804422A external-priority patent/GB8804422D0/en

1988-12-21 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1988-12-21 Publication of SE8804607D0 publication Critical patent/SE8804607D0/sv

1989-06-23 Publication of SE8804607L publication Critical patent/SE8804607L/sv

1995-09-25 Publication of SE502288C2 publication Critical patent/SE502288C2/sv

Links

239000002253 acid Substances 0.000 title 1
239000000203 mixture Substances 0.000 title 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title 1
239000013011 aqueous formulation Substances 0.000 abstract 3
238000002360 preparation method Methods 0.000 abstract 2
JAIYKLJZOBJGSG-UHFFFAOYSA-N 2-cyclopentyl-3-piperidin-1-ylhept-2-enoic acid Chemical class C1CCCC1C(C(O)=O)=C(CCCC)N1CCCCC1 JAIYKLJZOBJGSG-UHFFFAOYSA-N 0.000 abstract 1
QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 abstract 1
HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical class OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 abstract 1
WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical class OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 abstract 1
235000010290 biphenyl Nutrition 0.000 abstract 1
239000002775 capsule Substances 0.000 abstract 1
125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical class OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 abstract 1
239000007924 injection Substances 0.000 abstract 1
238000002347 injection Methods 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 abstract 1
235000020357 syrup Nutrition 0.000 abstract 1
239000006188 syrup Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biochemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nanotechnology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Materials Engineering (AREA)
Polymers & Plastics (AREA)
Biophysics (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Medical Informatics (AREA)
Crystallography & Structural Chemistry (AREA)
Pulmonology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Hydrogenated Pyridines (AREA)
Plural Heterocyclic Compounds (AREA)

SE8804607A 1987-12-22 1988-12-21 Vattenhaltig komposition innehållande ett piperidinylcyklopentylheptenonsyraderivat SE502288C2 (sv)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB878729823A GB8729823D0 (en)	1987-12-22	1987-12-22	Complexes
GB888804422A GB8804422D0 (en)	1988-02-25	1988-02-25	Complexes

Publications (3)

Publication Number	Publication Date
SE8804607D0 SE8804607D0 (sv)	1988-12-21
SE8804607L true SE8804607L (sv)	1989-06-23
SE502288C2 SE502288C2 (sv)	1995-09-25

Family

ID=26293226

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE8804607A SE502288C2 (sv)	1987-12-22	1988-12-21	Vattenhaltig komposition innehållande ett piperidinylcyklopentylheptenonsyraderivat

Country Status (29)

Country	Link
JP (1)	JPH02210A (sv)
KR (1)	KR890009402A (sv)
CN (1)	CN1034132A (sv)
AT (1)	AT395943B (sv)
AU (1)	AU615245B2 (sv)
BE (1)	BE1001704A3 (sv)
CA (1)	CA1328078C (sv)
CH (1)	CH676665A5 (sv)
DE (1)	DE3843059A1 (sv)
DK (1)	DK712888A (sv)
ES (1)	ES2011727A6 (sv)
FI (1)	FI885920A (sv)
FR (1)	FR2624731B1 (sv)
GB (1)	GB2211737B (sv)
GR (1)	GR880100854A (sv)
HU (1)	HU204700B (sv)
IE (1)	IE61995B1 (sv)
IL (1)	IL88764A0 (sv)
IT (1)	IT1224835B (sv)
LU (1)	LU87411A1 (sv)
MY (1)	MY103952A (sv)
NL (1)	NL8803126A (sv)
NO (1)	NO885689L (sv)
NZ (1)	NZ227446A (sv)
PH (1)	PH24982A (sv)
PL (1)	PL276595A1 (sv)
PT (1)	PT89301B (sv)
SE (1)	SE502288C2 (sv)
ZW (1)	ZW18088A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8814725D0 (en) *	1988-06-21	1988-07-27	Glaxo Group Ltd	Medicaments
AU616571B2 (en) *	1988-10-28	1991-10-31	Shiseido Company Ltd.	Cosmetic composition containing inclusion product with hydroxyalkylated cyclodextrin
IT1269578B (it) *	1994-04-22	1997-04-08	Chiesi Farma Spa	Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base.
KR100825736B1 (ko) *	2005-12-07	2008-04-29	한국전자통신연구원	무선 ｘｍｌ 전자 서명 서비스 제공 장치 및 그 방법
KR100832740B1 (ko) *	2007-01-17	2008-05-27	한국과학기술원	분지쇄 아미노산 생성능이 개선된 변이 미생물 및 이를이용한 분지쇄 아미노산의 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS503362B1 (sv) *	1970-06-10	1975-02-04
JPS5443569B2 (sv) *	1972-07-05	1979-12-20
HU181703B (en) *	1980-05-09	1983-11-28	Chinoin Gyogyszer Es Vegyeszet	Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents
JPS57183772A (en) *	1981-04-29	1982-11-12	Glaxo Group Ltd	Aminocyclopentanol acids and esters, manufacture and medicinal composition
JPS58116423A (ja) *	1981-12-28	1983-07-11	Sumitomo Chem Co Ltd	メタノプロスタサイクリン製剤組成物
JPS58192821A (ja) *	1982-04-30	1983-11-10	Dainippon Pharmaceut Co Ltd	脳神経細胞の酸素欠乏性疾患の治療剤
JPS5946228A (ja) *	1982-09-08	1984-03-15	Zeria Shinyaku Kogyo Kk	生物学的に活性な有機化合物の水溶性及びリンパ移行性薬剤の製造方法
JPS5973576A (ja) *	1982-09-16	1984-04-25	グラクソ・グル−プ・リミテツド	ピペリジニルシクロペンタノ−ルヘプテン酸塩
GB2127406B (en) *	1982-09-16	1986-03-05	Glaxo Group Ltd	Piperidinlycyclopentanolheptenoic acid salt
DE3346123A1 (de) *	1983-12-21	1985-06-27	Janssen Pharmaceutica, N.V., Beerse	Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
JPS60150039A (ja) *	1984-01-17	1985-08-07	Minolta Camera Co Ltd	水陸両用固定焦点カメラ
DE3504044A1 (de) *	1985-02-04	1986-08-07	Schering AG, Berlin und Bergkamen, 1000 Berlin	9-halogenprostaglandin-clathrate und ihre verwendung als arzneimittel
JPS6327440A (ja) *	1986-07-18	1988-02-05	Sanraku Inc	グルコシル化分岐シクロデキストリン含有組成物

1988
- 1988-12-21 HU HU886537A patent/HU204700B/hu not_active IP Right Cessation
- 1988-12-21 LU LU87411A patent/LU87411A1/fr unknown
- 1988-12-21 JP JP63320759A patent/JPH02210A/ja active Pending
- 1988-12-21 DK DK712888A patent/DK712888A/da not_active Application Discontinuation
- 1988-12-21 AU AU27356/88A patent/AU615245B2/en not_active Ceased
- 1988-12-21 BE BE8801423A patent/BE1001704A3/fr not_active IP Right Cessation
- 1988-12-21 AT AT0313088A patent/AT395943B/de not_active IP Right Cessation
- 1988-12-21 ZW ZW180/88A patent/ZW18088A1/xx unknown
- 1988-12-21 DE DE3843059A patent/DE3843059A1/de not_active Ceased
- 1988-12-21 FI FI885920A patent/FI885920A/fi not_active Application Discontinuation
- 1988-12-21 PT PT89301A patent/PT89301B/pt not_active IP Right Cessation
- 1988-12-21 PH PH37963A patent/PH24982A/en unknown
- 1988-12-21 GB GB8829793A patent/GB2211737B/en not_active Expired - Fee Related
- 1988-12-21 GR GR880100854A patent/GR880100854A/el unknown
- 1988-12-21 CH CH4758/88A patent/CH676665A5/de not_active IP Right Cessation
- 1988-12-21 NZ NZ227446A patent/NZ227446A/xx unknown
- 1988-12-21 CN CN88108916A patent/CN1034132A/zh active Pending
- 1988-12-21 ES ES8803876A patent/ES2011727A6/es not_active Expired - Fee Related
- 1988-12-21 NO NO88885689A patent/NO885689L/no unknown
- 1988-12-21 FR FR8816902A patent/FR2624731B1/fr not_active Expired - Fee Related
- 1988-12-21 PL PL27659588A patent/PL276595A1/xx unknown
- 1988-12-21 IE IE382088A patent/IE61995B1/en not_active IP Right Cessation
- 1988-12-21 KR KR1019880017106A patent/KR890009402A/ko not_active Application Discontinuation
- 1988-12-21 CA CA000586606A patent/CA1328078C/en not_active Expired - Fee Related
- 1988-12-21 IT IT8848702A patent/IT1224835B/it active
- 1988-12-21 SE SE8804607A patent/SE502288C2/sv not_active IP Right Cessation
- 1988-12-21 NL NL8803126A patent/NL8803126A/nl not_active Application Discontinuation
- 1988-12-22 MY MYPI88001508A patent/MY103952A/en unknown
- 1988-12-22 IL IL88764A patent/IL88764A0/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
NZ227446A (en)	1991-08-27
SE502288C2 (sv)	1995-09-25
SE8804607D0 (sv)	1988-12-21
AT395943B (de)	1993-04-26
ES2011727A6 (es)	1990-02-01
FR2624731A1 (fr)	1989-06-23
GB8829793D0 (en)	1989-02-15
IL88764A0 (en)	1989-07-31
PL276595A1 (en)	1989-08-21
LU87411A1 (fr)	1989-07-07
BE1001704A3 (fr)	1990-02-13
IT1224835B (it)	1990-10-24
IE61995B1 (en)	1994-12-14
GB2211737B (en)	1991-12-11
AU2735688A (en)	1989-06-22
FR2624731B1 (fr)	1992-10-23
ZW18088A1 (en)	1989-07-26
FI885920A (fi)	1989-06-23
CA1328078C (en)	1994-03-29
IE883820L (en)	1989-06-22
PH24982A (en)	1990-12-26
DK712888D0 (da)	1988-12-21
NO885689L (no)	1989-06-23
HU204700B (en)	1992-02-28
NO885689D0 (no)	1988-12-21
PT89301A (pt)	1990-06-29
GB2211737A (en)	1989-07-12
JPH02210A (ja)	1990-01-05
KR890009402A (ko)	1989-08-01
ATA313088A (de)	1992-09-15
MY103952A (en)	1993-10-30
AU615245B2 (en)	1991-09-26
CH676665A5 (sv)	1991-02-28
DK712888A (da)	1989-06-23
CN1034132A (zh)	1989-07-26
PT89301B (pt)	1995-07-03
HUT50040A (en)	1989-12-28
GR880100854A (el)	1994-03-31
IT8848702A0 (it)	1988-12-21
DE3843059A1 (de)	1989-07-13
NL8803126A (nl)	1989-07-17

Publication	Publication Date	Title
DK47186A (da)	1986-08-01	Alfa-(2-oxo-2,4,5,6,7,7a-hexahydrothieno(3,2-c)-5-pyridyl)phenyleddikesyrederivater og fremgangsmaade til fremstilling deraf samt deres terapeutiske anvendelse
DE3853922D1 (de)	1995-07-06	Aminosäurederivate als Amphotere.
AU588202B2 (en)	1989-09-07	Dosage form for delivering acid sensitive beneficial agent
DK356085A (da)	1986-02-07	Reninhaemmende peptid eller et farmaceutisk acceptabelt syreadditionssalt deraf
IL90423A (en)	2000-07-26	Interleukin-1 inhibitors methods for producing them pharmaceutical compositions containing them isolated DNA sequences encoding interleukin-1 inhibitors and host cells and vectors containing them
IT8720621A0 (it)	1987-05-21	Formulazioni di steroide in soluzione acquosa per somministrazione nasale.
ES2009723T3 (es)	1993-02-16	Derivados de acidos biliares, procedimientos para la preparacion de los mismos y composiciones farmaceuticas conteniendolos.
NO883054L (no)	1989-01-11	Fremgangsmaate for fremstilling av farmasoeytisk preparat inneholdende somatostatinanaloger.
NO884434L (no)	1989-04-07	Aminosyrederivater.
NO871599L (no)	1988-02-08	Sammensetning for stimulering av kondrocytter og osteoblaster (osseinhydroksyapatittforbindelse), fremgangsmaate for fremstilling derav og farmasoeytiske preparater inneholdende sammensetningen.
DE3766299D1 (de)	1991-01-03	4-chinolon-3-carbonsaeurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
SE8804607L (sv)	1989-06-23	Vattenformuleringar innehaallande ett piperidinylcyklopentylheptenonsyraderivat
FI883005A0 (fi)	1988-06-22	Promotorer foer expression av fraemmande dna i metylotrofiska bakterier, deras tillvaratagande och deras anvaendning.
ZA883240B (en)	1988-12-28	New 4-benzyl-1-(2h)-phthalazineone derivatives having an amino acid radical
DK229089A (da)	1989-11-12	Peptid-laegemiddelpraeparater indeholdende alfa-aminoborsyrederivater til indgift via slimhinden
IT1234068B (it)	1992-04-27	Sistema di connessione elastico per dentiere.
IE872475L (en)	1988-03-15	Acetic acid derivatives of 3-aryl-2,1-benzisoxazole
FR2596762B1 (fr)	1993-10-08	Derives d'acides nucleiques
ES8800666A1 (es)	1987-11-16	Procedimiento para la obtencion de derivados de 1,4-dihidropiridina
GB2153353B (en)	1987-07-15	Derivatives of b-(4-isocyano-1,2-3,4-diepoxycyclopenthyl)acrylic acid
GB2145413B (en)	1986-11-26	Phthalic acid derivatives which are substituted by 2-propynyloxy groups processes for their preparations and their use(
SE8703567D0 (sv)	1987-09-15	Aminosyralosning for intravenos infusion
ATE85615T1 (de)	1993-02-15	3-pyrrolidinylthio-1-azabicyclo(3.2.0>hept-2-en 2-carbonsaeure-derivate.
IE871497L (en)	1987-12-06	Derivatives of 4-phenyl-4-oxo-2-butenoic acid.
SE8304972D0 (sv)	1983-09-15	Piperidinylcyklopentanolheptensyrasalt

Legal Events

Date	Code	Title	Description
1997-09-08	NUG	Patent has lapsed	Ref document number: 8804607-3 Format of ref document f/p: F

Date

Code

Title

Description

1997-09-08

NUG

Patent has lapsed

Ref document number: 8804607-3

Format of ref document f/p: F